Mike Baxter

489 total citations
23 papers, 377 citations indexed

About

Mike Baxter is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Mike Baxter has authored 23 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Mike Baxter's work include Diabetes Management and Research (17 papers), Diabetes Treatment and Management (16 papers) and Metabolism, Diabetes, and Cancer (6 papers). Mike Baxter is often cited by papers focused on Diabetes Management and Research (17 papers), Diabetes Treatment and Management (16 papers) and Metabolism, Diabetes, and Cancer (6 papers). Mike Baxter collaborates with scholars based in United Kingdom, United States and Japan. Mike Baxter's co-authors include Nick Hex, Chris Bartlett, Yevgeniy Samyshkin, James Mahon, A. Roy, Manas Pratim Roy, Emma G. Wilmot, Lalantha Leelarathna, Pratik Choudhary and James D. Walker and has published in prestigious journals such as Fertility and Sterility, Diabetic Medicine and Diabetes Obesity and Metabolism.

In The Last Decade

Mike Baxter

23 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike Baxter United Kingdom	11	258	119	70	53	48	23	377
Mary Selwood United Kingdom	6	113 0.4×	139 1.2×	137 2.0×	32 0.6×	53 1.1×	7	390
Mary Burden United Kingdom	10	172 0.7×	70 0.6×	74 1.1×	40 0.8×	17 0.4×	36	316
Line Kleinebreil France	6	621 2.4×	75 0.6×	86 1.2×	65 1.2×	66 1.4×	16	730
Gregory E. Peterson United States	7	358 1.4×	127 1.1×	88 1.3×	44 0.8×	48 1.0×	8	471
Eileen Turner United Kingdom	7	500 1.9×	122 1.0×	146 2.1×	74 1.4×	35 0.7×	14	649
Elke Witthaus United Kingdom	7	267 1.0×	71 0.6×	70 1.0×	39 0.7×	29 0.6×	7	358
Allison Dart Canada	11	226 0.9×	88 0.7×	126 1.8×	55 1.0×	59 1.2×	30	555
Frances Wright United States	4	493 1.9×	108 0.9×	148 2.1×	55 1.0×	23 0.5×	6	582
Anthony Pease Australia	11	375 1.5×	144 1.2×	182 2.6×	38 0.7×	15 0.3×	17	445
Saskia Vanderloo Canada	8	246 1.0×	77 0.6×	37 0.5×	40 0.8×	114 2.4×	12	428

Countries citing papers authored by Mike Baxter

Since Specialization

Citations

This map shows the geographic impact of Mike Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Baxter more than expected).

Fields of papers citing papers by Mike Baxter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Baxter. The network helps show where Mike Baxter may publish in the future.

Co-authorship network of co-authors of Mike Baxter

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Baxter. A scholar is included among the top collaborators of Mike Baxter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Baxter. Mike Baxter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dessapt-Baradez, Cécile, et al.. (2024). A Systematic Literature Review of Psychological Interventions for Adults with Type 1 Diabetes. Diabetes Therapy. 15(2). 367–380. 2 indexed citations

Brulle-Wohlhueter, Claire, et al.. (2022). Brief Digital Solutions in Behavior Change Interventions for Type 2 Diabetes Mellitus: A Literature Review. Diabetes Therapy. 13(4). 635–649. 12 indexed citations

Miyoshi, Hideaki, et al.. (2021). A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes. Diabetes Therapy. 12(5). 1341–1357. 1 indexed citations

McCrimmon, Rory J., et al.. (2021). Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK. Diabetes Therapy. 12(12). 3217–3230. 10 indexed citations

Iizuka, Katsumi, Mike Baxter, Daisuke Watanabe, & Daisuke Yabe. (2021). Benefit of insulin glargine/lixisenatide for reducing residual hyperglycaemia in J apan: Post hoc analysis of the LixiLan JP‐O2 trial. Diabetes Obesity and Metabolism. 23(12). 2795–2803. 4 indexed citations

Baxter, Mike, et al.. (2020). A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes. Diabetes Therapy. 11(7). 1481–1496. 12 indexed citations

Kaneto, Hideaki, Ryusuke Koshida, & Mike Baxter. (2020). Fixed‐ratio combination of basal insulin and glucagon‐like peptide‐1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge. Diabetes Obesity and Metabolism. 22(S4). 24–34. 8 indexed citations

Terauchi, Yasuo, Daisuke Yabe, Hideaki Kaneto, et al.. (2020). Benefits of the fixed‐ratio combination of insulin glargine 100 units/ mL and lixisenatide ( iGlarLixi ) in Japanese people with type 2 diabetes: A subgroup and time‐to‐control analysis of the LixiLan JP phase 3 trials. Diabetes Obesity and Metabolism. 22(S4). 35–47. 5 indexed citations

Bain, Stephen C., Michael Feher, Miles Fisher, et al.. (2019). A review of the NG17 recommendations for the use of basal insulin in type 1 diabetes. Diabetic Medicine. 37(2). 219–228. 3 indexed citations

10.

Wilmot, Emma G., Pratik Choudhary, Lalantha Leelarathna, & Mike Baxter. (2019). Glycaemic variability: The under‐recognized therapeutic target in type 1 diabetes care. Diabetes Obesity and Metabolism. 21(12). 2599–2608. 37 indexed citations

11.

Davies, Melanie J., David Russell‐Jones, Thomas M. Barber, et al.. (2019). Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial. Diabetes Obesity and Metabolism. 21(8). 1967–1972. 15 indexed citations

12.

Field, Benjamin C. T., et al.. (2018). A retrospective observational study of people with Type 1 diabetes with self‐reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist intervention. Diabetic Medicine. 35(9). 1223–1231. 5 indexed citations

13.

Bain, Stephen C., Neil Black, Daisy Elliott, et al.. (2018). A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA). Diabetic Medicine. 36(1). 110–119. 17 indexed citations

14.

Baxter, Mike, et al.. (2011). Geriatrician input into nursing homes reduces emergency hospital admissions. Archives of Gerontology and Geriatrics. 55(2). 331–337. 27 indexed citations

15.

Baxter, Mike. (2008). Treatment of type 2 diabetes: a structured management plan. Advances in Therapy. 25(2). 106–114. 4 indexed citations

16.

Baxter, Mike. (2008). The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes. Acta Diabetologica. 45(4). 253–268. 26 indexed citations

17.

Baxter, Mike. (2006). Translating health care messages into beneficial behavioural change. Practical Diabetes International. 23(3). 110–110. 1 indexed citations

18.

Mullin, Christine, et al.. (2005). Day 3 Follicle Stimulating Hormone (FSH) and Estradiol (E2): Could These Values be used as Markers to Predict Pregnancy Outcomes in Women Undergoing Ovulation Induction (OI) Therapy With Intrauterine Insemination (IUI) Cycles?. Fertility and Sterility. 84. S162–S162. 6 indexed citations

19.

Masson, E. A., Mike Baxter, Gordon Caldwell, et al.. (2003). Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). Diabetic Medicine. 20(1). 46–50. 46 indexed citations

20.

Roy, Manas Pratim, Mike Baxter, & A. Roy. (1990). Atlantoaxial Instability in down Syndrome-Guidelines for Screening and Detection. Journal of the Royal Society of Medicine. 83(7). 433–435. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact